Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist
Antonio Martínez‐López, Carlos Cuenca‐Barrales, Trinidad Montero‐Vílchez, Alejandro Molina‐Leyva, Salvador Arias‐Santiago
Topics & Concepts
MedicineHydroxychloroquineDermatologyLopinavirAnakinraTocilizumabAdverse effectFavipiravirRashPneumoniaRitonavirRibavirinCoronavirus disease 2019 (COVID-19)PharmacologyImmunologyInternal medicineRheumatoid arthritisViral loadVirusHepatitis C virusDiseaseAntiretroviral therapyInfectious disease (medical specialty)Dermatological and COVID-19 studiesDrug-Induced Adverse ReactionsHeparin-Induced Thrombocytopenia and Thrombosis